Literature DB >> 24008302

Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Emily Cousins1, John Nicholas.   

Abstract

Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the second identified human gammaherpesvirus. Like its relative Epstein-Barr virus, HHV-8 is linked to B-cell tumors, specifically primary effusion lymphoma and multicentric Castleman's disease, in addition to endothelial-derived KS. HHV-8 is unusual in its possession of a plethora of "accessory" genes and encoded proteins in addition to the core, conserved herpesvirus and gammaherpesvirus genes that are necessary for basic biological functions of these viruses. The HHV-8 accessory proteins specify not only activities deducible from their cellular protein homologies but also novel, unsuspected activities that have revealed new mechanisms of virus-host interaction that serve virus replication or latency and may contribute to the development and progression of virus-associated neoplasia. These proteins include viral interleukin-6 (vIL-6), viral chemokines (vCCLs), viral G protein-coupled receptor (vGPCR), viral interferon regulatory factors (vIRFs), and viral antiapoptotic proteins homologous to FLICE (FADD-like IL-1β converting enzyme)-inhibitory protein (FLIP) and survivin. Other HHV-8 proteins, such as signaling membrane receptors encoded by open reading frames K1 and K15, also interact with host mechanisms in unique ways and have been implicated in viral pathogenesis. Additionally, a set of micro-RNAs encoded by HHV-8 appear to modulate expression of multiple host proteins to provide conditions conducive to virus persistence within the host and could also contribute to HHV-8-induced neoplasia. Here, we review the molecular biology underlying these novel virus-host interactions and their potential roles in both virus biology and virus-associated disease.

Entities:  

Mesh:

Year:  2014        PMID: 24008302      PMCID: PMC4124616          DOI: 10.1007/978-3-642-38965-8_13

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  258 in total

1.  MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms.

Authors:  Yan Zeng; Rui Yi; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-05       Impact factor: 11.205

2.  Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.

Authors:  Young C Shin; Chul-Hyun Joo; Michaela U Gack; Hye-Ra Lee; Jae U Jung
Journal:  Cancer Res       Date:  2008-03-15       Impact factor: 12.701

3.  Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation?

Authors:  F Samaniego; S Pati; J E Karp; O Prakash; D Bose
Journal:  J Natl Cancer Inst Monogr       Date:  2001

4.  The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter.

Authors:  Hong Li; Takashi Komatsu; Bruce J Dezube; Kenneth M Kaye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus.

Authors:  Y Aoki; M Narazaki; T Kishimoto; G Tosato
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

6.  Identification of the R1 oncogene and its protein product from the rhadinovirus of rhesus monkeys.

Authors:  B Damania; M Li; J K Choi; L Alexander; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.

Authors:  Johanna R Abend; Thomas Uldrick; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host.

Authors:  Sam Mbulaiteye; Vickie Marshall; Rachel K Bagni; Cheng-Dian Wang; Georgina Mbisa; Paul M Bakaki; Anchilla M Owor; Christopher M Ndugwa; Eric A Engels; Edward Katongole-Mbidde; Robert J Biggar; Denise Whitby
Journal:  J Infect Dis       Date:  2006-03-17       Impact factor: 5.226

10.  The latency protein LANA2 from Kaposi's sarcoma-associated herpesvirus inhibits apoptosis induced by dsRNA-activated protein kinase but not RNase L activation.

Authors:  M Esteban; M A García; E Domingo-Gil; J Arroyo; C Nombela; C Rivas
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

View more
  16 in total

1.  Modulation of Mitochondrial Antiviral Signaling by Human Herpesvirus 8 Interferon Regulatory Factor 1.

Authors:  Keun Young Hwang; Young Bong Choi
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

2.  Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.

Authors:  Fan Sun; Yadong Xiao; Zhaoxia Qu
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

3.  The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression.

Authors:  Hui-Chen Chang Foreman; Julie Armstrong; Alexis L Santana; Laurie T Krug; Nancy C Reich
Journal:  J Biol Chem       Date:  2017-08-15       Impact factor: 5.157

Review 4.  Chemokines encoded by herpesviruses.

Authors:  Sergio M Pontejo; Philip M Murphy
Journal:  J Leukoc Biol       Date:  2017-08-28       Impact factor: 4.962

5.  Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway.

Authors:  Gavin Golas; Seung Jin Jang; Nenavath Gopal Naik; Juan D Alonso; Bernadett Papp; Zsolt Toth
Journal:  Virology       Date:  2019-12-30       Impact factor: 3.616

6.  Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor.

Authors:  Haidai Hu; Jiazhen Dong; Deguang Liang; Zengqiang Gao; Lei Bai; Rui Sun; Hao Hu; Heng Zhang; Yuhui Dong; Ke Lan
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

7.  Human Herpesvirus 8 Interferon Regulatory Factors 1 and 3 Mediate Replication and Latency Activities via Interactions with USP7 Deubiquitinase.

Authors:  Qiwang Xiang; Hyunwoo Ju; Qian Li; Szu-Chieh Mei; Daming Chen; Young Bong Choi; John Nicholas
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 8.  Molecular biology of KSHV lytic reactivation.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Subhash C Verma
Journal:  Viruses       Date:  2015-01-14       Impact factor: 5.048

Review 9.  KSHV LANA--the master regulator of KSHV latency.

Authors:  Timsy Uppal; Sagarika Banerjee; Zhiguo Sun; Subhash C Verma; Erle S Robertson
Journal:  Viruses       Date:  2014-12-11       Impact factor: 5.048

10.  MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling.

Authors:  Shuihong Yao; Minmin Hu; Tingting Hao; Wan Li; Xue Xue; Min Xue; Xiaofei Zhu; Feng Zhou; Di Qin; Qin Yan; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  Nucleic Acids Res       Date:  2015-10-07       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.